Multiple strategies to activate gold nanoparticles as antibiotics

被引:147
作者
Zhao, Yuyun [1 ]
Jiang, Xingyu [1 ]
机构
[1] Natl Ctr NanoSci & Technol, CAS Key Lab Biol Effects Nanomat & Nanosafety, Beijing 100190, Peoples R China
基金
美国国家科学基金会;
关键词
PSEUDOMONAS-AERUGINOSA; ANTIBACTERIAL ACTIVITY; IN-VIVO; STAPHYLOCOCCUS-AUREUS; OXIDATIVE STRESS; DRUG; TOXICITY; BACTERIA; SILVER; RESISTANCE;
D O I
10.1039/c3nr01990j
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Widespread antibiotic resistance calls for new strategies. Nanotechnology provides a chance to overcome antibiotic resistance by multiple antibiotic mechanisms. This paper reviews the progress in activating gold nanoparticles with nonantibiotic or antibiotic molecules to combat bacterial resistance, analyzes the gap between experimental achievements and real clinical application, and suggests some potential directions in developing antibacterial nanodrugs.
引用
收藏
页码:8340 / 8350
页数:11
相关论文
共 124 条
[1]   Development of gentamicin-gold nanospheres for antimicrobial drug delivery to Staphylococcal infected foci [J].
Ahangari, Azam ;
Salouti, Mojtaba ;
Heidari, Zahra ;
Kazemizadeh, Ali Reza ;
Safari, Ali Asghar .
DRUG DELIVERY, 2013, 20 (01) :34-39
[2]   Interventional strategies and current clinical experience with carbapenemase-producing Gram-negative bacteria [J].
Akova, M. ;
Daikos, G. L. ;
Tzouvelekis, L. ;
Carmeli, Y. .
CLINICAL MICROBIOLOGY AND INFECTION, 2012, 18 (05) :439-448
[3]   Molecular mechanisms of antibacterial multidrug resistance [J].
Alekshun, Michael N. ;
Levy, Stuart B. .
CELL, 2007, 128 (06) :1037-1050
[4]  
Allahverdiyev AM, 2011, EXPERT REV ANTI-INFE, V9, P1035, DOI [10.1586/eri.11.121, 10.1586/ERI.11.121]
[5]  
[Anonymous], GUID IND CONT FORM I
[6]  
[Anonymous], 2011, UPD RISK ASS SPREAD
[7]  
Apisarnthanarak A, 2013, EXPERT REV ANTI-INFE, V11, P147, DOI [10.1586/ERI.12.164, 10.1586/eri.12.164]
[8]   The enhanced permeability retention effect: a new paradigm for drug targeting in infection [J].
Azzopardi, Ernest A. ;
Ferguson, Elaine L. ;
Thomas, David W. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (02) :257-274
[9]  
Bassetti M, 2011, EXPERT REV ANTI-INFE, V9, P909, DOI [10.1586/ERI.11.107, 10.1586/eri.11.107]
[10]  
Blecher K., 2013, NANOTECHNOLOGY DERMA, P187